TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Debt-to-equity in % from Q4 2010 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Teva Pharmaceutical Industries Ltd quarterly Debt-to-equity history and growth rate from Q4 2010 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Debt-to-equity for the quarter ending September 30, 2024 was 517 %, a 9.07% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 517 +43 +9.07% Sep 30, 2024
Q2 2024 499 +52.3 +11.7% Jun 30, 2024
Q1 2024 489 +67.5 +16% Mar 31, 2024
Q4 2023 479 +69.5 +17% Dec 31, 2023
Q3 2023 474 +89.2 +23.2% Sep 30, 2023
Q2 2023 447 +74.2 +19.9% Jun 30, 2023
Q1 2023 422 +57 +15.6% Mar 31, 2023
Q4 2022 409 +47.2 +13% Dec 31, 2022
Q3 2022 385 +12.9 +3.46% Sep 30, 2022
Q2 2022 372 -14.7 -3.78% Jun 30, 2022
Q1 2022 365 +4.02 +1.11% Mar 31, 2022
Q4 2021 362 +22.5 +6.63% Dec 31, 2021
Q3 2021 372 +53.3 +16.7% Sep 30, 2021
Q2 2021 387 +86.8 +28.9% Jun 30, 2021
Q1 2021 361 +54.8 +17.9% Mar 31, 2021
Q4 2020 340 +34.2 +11.2% Dec 31, 2020
Q3 2020 319 +13 +4.25% Sep 30, 2020
Q2 2020 300 +8.28 +2.84% Jun 30, 2020
Q1 2020 306 +25.8 +9.21% Mar 31, 2020
Q4 2019 305 +33.6 +12.4% Dec 31, 2019
Q3 2019 306 +34.4 +12.7% Sep 30, 2019
Q2 2019 292 +44.6 +18% Jun 30, 2019
Q1 2019 280 +49.9 +21.7% Mar 31, 2019
Q4 2018 272 +68.3 +33.5% Dec 31, 2018
Q3 2018 272 +89.2 +48.9% Sep 30, 2018
Q2 2018 247 +69.6 +39.2% Jun 30, 2018
Q1 2018 230 +78.7 +51.9% Mar 31, 2018
Q4 2017 204 +71.7 +54.3% Dec 31, 2017
Q3 2017 182 +73.6 +67.7% Sep 30, 2017
Q2 2017 178 +89 +100% Jun 30, 2017
Q1 2017 152 +55.6 +57.8% Mar 31, 2017
Q4 2016 132 +28.4 +27.5% Dec 31, 2016
Q3 2016 109 -0.66 -0.6% Sep 30, 2016
Q2 2016 88.8 -16.5 -15.7% Jun 30, 2016
Q1 2016 96.1 -4.22 -4.21% Mar 31, 2016
Q4 2015 103 +3.95 +3.97% Dec 31, 2015
Q3 2015 109 +7.12 +6.96% Sep 30, 2015
Q2 2015 105 -1.19 -1.12% Jun 30, 2015
Q1 2015 100 -11.7 -10.4% Mar 31, 2015
Q4 2014 99.5 -14.4 -12.6% Dec 31, 2014
Q3 2014 102 -14.6 -12.5% Sep 30, 2014
Q2 2014 107 -10.7 -9.11% Jun 30, 2014
Q1 2014 112 -3.7 -3.2% Mar 31, 2014
Q4 2013 114 -3.6 -3.06% Dec 31, 2013
Q3 2013 117 -1.44 -1.22% Sep 30, 2013
Q2 2013 117 +7.8 +7.13% Jun 30, 2013
Q1 2013 116 +17.9 +18.3% Mar 31, 2013
Q4 2012 117 +31.8 +37.1% Dec 31, 2012
Q3 2012 118 +45.1 +61.6% Sep 30, 2012
Q2 2012 109 +36.4 +49.8% Jun 30, 2012
Q1 2012 97.9 +21.8 +28.6% Mar 31, 2012
Q4 2011 85.7 +8.59 +11.1% Dec 31, 2011
Q3 2011 73.2 Sep 30, 2011
Q2 2011 73 Jun 30, 2011
Q1 2011 76.1 Mar 31, 2011
Q4 2010 77.1 Dec 31, 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.